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reveals confluent hyperintense signals in 
the deep and periventricular white matter, 
characteristically in the temporal poles 
and the capsula extrema  [6] . 
 Herein we describe a patient with mo-
lecular genetically diagnosed mitochon-
drial cytopathy with MRI findings strong-
ly resembling CADASIL. 
 Case Report 
 A 48-year-old woman was admitted to 
our department for the evaluation of bilat-
eral ptosis and restricted eye movements. 
Her personal medical history was un-
eventful, and there were no neurological 
disorders reported from other family 
members. At the age of 45 years she no-
ticed drooping eyelids, impaired visual 
ability at night, exercise-dependent leg 
weakness and fatigability. Over the follow-
ing years, symptoms deteriorated and she 
had to give up her job as a sewer. In addi-
tion, she reported pulsating headaches 
without accompanying vegetative symp-
toms. She had no complaints regarding her 
memory, and she did not report epileptic 
seizures or stroke-like episodes. 
 General examination revealed short 
stature (1.48 m) and obesity. Neurological 
examination showed bilateral right-domi-
nant ptosis and external ophthalmoplegia. 
Funduscopy as well as other cranial nerve 
functions were normal. There was no atro-
 Dear Sir, 
 Mitochondrial cytopathies due to mi-
tochondrial DNA (mtDNA) mutations 
represent a heterogeneous group of respi-
ratory chain disorders associated with 
variable systemic, muscular, peripheral 
and central nervous system involvement. 
Heteroplasmy and a threshold effect are 
responsible for the variability of clinical 
manifestations. Prototypic neurological 
phenotypes include mitochondrial en-
cephalomyopathy, lactic acidosis, and 
stroke-like episodes (MELAS), myoclonus 
epilepsy with ragged-red fibers (MERRF), 
neuropathy, ataxia, and retinitis pigmen-
tosa (NARP), and maternally inherited in-
fantile subacute encephalomyelopathy 
(Leigh’s syndrome)  [1] . 
 Cerebral autosomal dominant arteri-
opathy with subcortical infarcts and leu-
koencephalopathy (CADASIL) is an auto-
somal dominant disorder caused by muta-
tions in the  Notch3 gene. Clinically, 
CADASIL is characterized by recurrent 
ischemic strokes, migraine with or with-
out aura, psychiatric symptoms, and cog-
nitive decline, and it is assumed to be an 
underdiagnosed reason of ischemic stroke 
 [2, 3] . Diagnosis of CADASIL is achieved 
by molecular genetic testing of the  Notch3 
gene, or by skin biopsy revealing charac-
teristic granular osmiophilic deposits in 
vascular smooth muscle cells  [2, 4, 5] . 
Brain magnetic resonance imaging (MRI) 
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phy, muscle tone was normal, but there 
was moderate proximal paresis of the legs 
(M4 to M5; MRC grading). There was a 
slight bilateral brady-dysdiadochokinesia, 
and walking with closed eyes was slightly 
ataxic. Tendon reflexes were bilaterally 
weak, and plantar responses were flexor. 
 Laboratory workup showed elevated 
creatine kinase (190 U/I; normal for our 
laboratory  ! 167) and serum lactate levels 
(3.4 mmol/l; normal  ! 2.4), while serum 
glucose and pyruvate were within the nor-
mal range. EEG demonstrated slight gen-
eral slowing with theta activity. Electro-
neurography and cardiologic investiga-
tions including echocardiography were 
normal. Biopsy of the left quadriceps re-
vealed mild myopathic changes consisting 
of variability of fiber diameter, elongated 
fibers, and some internalized nuclei. Im-
munohistochemistry revealed no red 
ragged fibers (trichrome stain), and nor-
mal staining for mitochondrial enzyme 
activity (COX, NADH, and SDH stains). 
Electron microscopy of multiple skin and 
muscle vessels did not demonstrate granu-
lar osmiophilic deposits in the vascular 
smooth muscle cells. 
 Neuroradiology 
 MRI and magnetic resonance spectros-
copy (MRS) were performed on a 3T Phil-
ips Achieva whole-body MRI system (Phil-
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ips Medical Systems, Best, The Nether-
lands) using a transmit/receive head coil. 
T 2 -weighted MRI sequences showed pro-
nounced confluent hyperintense lesions in 
the white matter of the anterior temporal 
poles and marked hyperintense lesions in 
the capsula extrema bilaterally. In addi-
tion, there were some circumscribed hy-
perintense lesions in the subcortical white 
matter as well as confluent subcortical le-
sions in the frontal regions ( fig. 1 A–C). No 
lesions suspicious for microhemorrhages 
were detected and there was no pathologi-
cal contrast enhancement. Diffusion-
weighted imaging and ADC mapping have 
not been performed. 
 1 H-MRS data were acquired using 
high-resolution multi-spin echo spectro-
scopic imaging (TSI; TE = 288 ms, slice 
thickness = 1.5 cm, resolution 28  ! 28, 
FOV = 220 mm)  [7] and conventional 
chemical shift imaging (CSI; TE = 35 ms, 
resolution 16  ! 16 and TE = 288 ms, reso-
lution 12  ! 12, NSA = 2; slice thickness = 
2 cm, FOV = 220 mm). For all measure-
ments the bandwidth was 2,500 Hz and 
the repetition time TR = 1,520. The data 
were received from axial slice, which was 
adjusted parallel to the calcarine fissure 
including the visual cortex. Regions of in-
terest were selected in the subcortical 
white matter. Signal localization was 
achieved by use of point-resolved spec-
troscopy, and chemical shift selective exci-
tation in combination with a dephasing 
gradient was used for water suppression. 
Spectral data were postprocessed using a 
constant baseline correction, B 0  correc-
tion, exponential spectral filtering by 2 Hz 
and Gaussian filtering of 3 Hz as well as 
linear phase correction. Relative metabo-
lite concentrations were determined using 
LC Model. CSI showed a lactate double 
peak in the occipital cortical and subcorti-
cal brain regions bilaterally ( fig. 2 A). TSI 
revealed an alanine double peak in the 
frontal cortical brain regions ( fig. 2 B). 
 Molecular Genetic Analysis 
 Total DNA was extracted from EDTA-
blood and skeletal muscle according to 
standard isolation protocols (Qiagen, 
Hilden, Germany). Screening for large-
scale mtDNA rearrangements and point 
mutations was performed by long template 
polymerase chain reaction and single-
strand conformation polymorphism, re-
spectively. Abnormal conformers were di-
rectly sequenced on an ABI 377 DNA Se-
quencer (Applied Biosystems, Forster City, 
Calif., USA). No pathogenic point muta-
tions but an 8.3-kb deletion in 28–36% of 
the mtDNA population of the muscle was 
detected. No deleted mtDNA was found in 
the blood. Amplification and sequencing 
of the entire  Notch3 gene on both strands 
and including exon-intron boundaries 
were performed using standard methods 
(Dr. R. Spiegel, Genetica, Human Genetic 
Laboratory, Zurich, Switzerland). No mu-
tations were detected. 
 Discussion 
 A mitochondrial cytopathy in our pa-
tient was strongly suggested by the clinical 
pattern including short stature, progres-
sive external ophthalmoplegia, and myop-
athy, as well as by the laboratory findings 
of elevated serum lactate and creatine ki-
nase levels. The diagnosis was finally con-
firmed by molecular genetic analysis of the 
mitochondrial genome revealing a hetero-
plasmic 8.3-kb deletion in the skeletal 
muscle. 
 The CSI MRS results were in line with 
the diagnosis of a mitochondrial cytopa-
thy and demonstrated a lactate doublet 
peak in occipital areas, reflecting a dysbal-
ance between glycolysis and oxidative res-
piration. In addition, TSI MRS revealed a 
high alanine peak in the frontal lobe. Ele-
vated alanine levels may be seen in patients 
with mitochondrial encephalopathy  [8] . 
 Fig. 1. MRI.  A ,  B T 2 -weighted MR images demonstrate confluent hyperintense signal alterations in the subcor-
tical white matter of the anterior temporal poles ( A ) and the capsula extrema ( B ) bilaterally.  C In addition, there 
are circumscribed hyperintense signal alterations in the subcortical cerebral white matter which are confluent 
in the frontal regions. 
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However, elevated alanine has also been 
described in animal models of ischemic 
brain injury, where it was interpreted as a 
general marker of ischemia  [9, 10] . In con-
trast, main cerebral MRS findings in CA-
DASIL patients included decreased N-ace-
tyl aspartate, creatine and choline in path-
ological as well as normal-appearing white 
matter, whereas lactate was hardly visible 
in individual patient spectra and no ala-
nine was detected  [11] . 
 Cerebral MRI alterations in mitochon-
drial encephalopathies are usually expect-
ed to be homogeneous and equally distrib-
uted in cortical and subcortical areas  [12] . 
In our patient, however, there were cir-
cumscribed alterations in the anterior 
temporal poles, the capsula extrema and 
the subcortical white matter. This particu-
lar lesion pattern has been proposed to be 
suggestive of CADASIL  [6, 13] . Compared 
to MRI alterations of patients with pre-
sumably sporadic cerebral small vessel 
disease without  Notch3 mutations, in-
volvement of the temporal pole had a sen-
sitivity of 89% and a specificity of 86% for 
the diagnosis of CADASIL  [6] . Involve-
ment of the external capsule was less spe-
cific and had a sensitivity of 93% and a low 
specificity of 45%  [6] . 
 Based on the negative skin biopsy and 
 Notch3 gene analysis, coincidental CADA-
SIL in our patient can be practically ex-
cluded. Our findings therefore demon-
strate an overlapping neuroradiological 
presentation of the two disorders. CADA-
SIL and some phenotypes of mitochondri-
al encephalopathies also share several 
clinical characteristics such as migraine 
and stroke-like episodes, raising the ques-
tion of common pathogenic mechanisms. 
Clinical peripheral nerve or muscle in-
volvement, a hallmark of mitochondrial 
cytopathies, is not evident in CADASIL. 
However, several independent CADASIL 
families carrying different  Notch3 muta-
tions had muscle mitochondrial abnor-
malities  [14–16] . In a morphological study, 
abnormal mitochondria containing para-
crystalline inclusions were detected, but 
these abnormalities were not associated 
with mitochondrial dysfunction or mt-
DNA mutations  [16] . Another CADASIL 
patient had coincident mtDNA and  Notch3 
mutations  [14] , and a recent study demon-
strated an increased rate of mtDNA se-
quence variations within CADASIL pedi-
grees  [17] . In addition, experimental data 
of a lethal mutation of the Drosophila 
Notch3 gene revealed a significantly de-
creased activity of two respiratory chain 
complexes, NADH dehydrogenase and 
ATP synthase  [15] . 
 In conclusion, mitochondrial encepha-
lopathy may be associated with anterior 
temporal lobe changes thought to be spe-
cific of CADASIL. MRI and MRS studies 
might be useful tools in identifying over-
lap and co-occurrence of these two disor-
ders, and might contribute to a better un-
derstanding of their pathophysiological 
intersections. 
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 Fig. 2. MRS.  A  1 H-MR spectrum, corresponding to the voxel shown in the right occipital region, obtained by 
CSI measurement, TE = 288 ms. The arrow indicates the lactate double peak at 1.33 ppm.  B  1 H-MR spectrum, 
corresponding to the voxel shown in the left frontal region, obtained by TSI measurement, TE = 288 ms. The 
arrow indicates the alanine double peak at 1.48 ppm. 
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